DD204924A5 - Verfahren zur herstellung n-substituierter 2-pyridylindole - Google Patents

Verfahren zur herstellung n-substituierter 2-pyridylindole Download PDF

Info

Publication number
DD204924A5
DD204924A5 DD82244959A DD24495982A DD204924A5 DD 204924 A5 DD204924 A5 DD 204924A5 DD 82244959 A DD82244959 A DD 82244959A DD 24495982 A DD24495982 A DD 24495982A DD 204924 A5 DD204924 A5 DD 204924A5
Authority
DD
German Democratic Republic
Prior art keywords
pyridyl
formula
compound
methyl
indole
Prior art date
Application number
DD82244959A
Other languages
German (de)
English (en)
Inventor
Harris B Renfroe
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of DD204924A5 publication Critical patent/DD204924A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DD82244959A 1981-11-19 1982-11-17 Verfahren zur herstellung n-substituierter 2-pyridylindole DD204924A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32301881A 1981-11-19 1981-11-19

Publications (1)

Publication Number Publication Date
DD204924A5 true DD204924A5 (de) 1983-12-14

Family

ID=23257445

Family Applications (1)

Application Number Title Priority Date Filing Date
DD82244959A DD204924A5 (de) 1981-11-19 1982-11-17 Verfahren zur herstellung n-substituierter 2-pyridylindole

Country Status (22)

Country Link
EP (1) EP0080154B1 (fi)
JP (1) JPS5892677A (fi)
KR (1) KR880002010B1 (fi)
AR (3) AR241428A1 (fi)
AT (1) ATE15196T1 (fi)
AU (1) AU564233B2 (fi)
CA (1) CA1197249A (fi)
DD (1) DD204924A5 (fi)
DE (1) DE3265892D1 (fi)
DK (1) DK169104B1 (fi)
ES (4) ES8501755A1 (fi)
FI (1) FI75344C (fi)
GB (1) GB2111050B (fi)
GR (1) GR77035B (fi)
HU (1) HU190425B (fi)
IE (1) IE54156B1 (fi)
IL (1) IL67284A (fi)
NO (1) NO159929C (fi)
NZ (1) NZ202551A (fi)
PH (1) PH19212A (fi)
PT (1) PT75870B (fi)
ZA (1) ZA828505B (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4511573A (en) * 1983-05-17 1985-04-16 Ciba-Geigy Corporation 3-Substituted-2-(heteroaryl) indoles
GB8524157D0 (en) * 1984-10-19 1985-11-06 Ici America Inc Heterocyclic amides
US4675332A (en) * 1984-12-10 1987-06-23 Warner-Lambert Company Acidic tetrazolyl substituted indole compounds and their use as antiallergy agents
US4609733A (en) * 1984-12-27 1986-09-02 Ciba-Geigy Corporation 3-keto-substituted-N-pyridylindoles
GB8626297D0 (en) * 1986-11-04 1986-12-03 Ici Plc Pharmaceutical compositions
GB8626296D0 (en) * 1986-11-04 1986-12-03 Ici Plc Therapeutic agents
GB9319100D0 (en) * 1993-09-15 1993-11-03 Pfizer Ltd 3-(3-pyridinyl)h-indoles
CA2140722A1 (en) * 1994-01-24 1995-07-25 Joseph A. Jakubowski Beta-carboline thromboxane synthase inhibitors
US6828344B1 (en) * 1998-02-25 2004-12-07 Genetics Institute, Llc Inhibitors of phospholipase enzymes
GB0307891D0 (en) * 2003-04-04 2003-05-14 Angeletti P Ist Richerche Bio Chemical compounds,compositions and uses
AR072297A1 (es) * 2008-06-27 2010-08-18 Novartis Ag Derivados de indol-2-il-piridin-3-ilo, composicion farmaceutica que los comprende y su uso en medicamentos para el tratamiento de enfermedades mediadas por la sintasa aldosterona.
WO2019118799A1 (en) * 2017-12-15 2019-06-20 Bristol-Myers Squibb Company Substituted indole ether compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3468894A (en) * 1966-11-29 1969-09-23 Geigy Chem Corp Certain 2-pyridyl-substituted indole derivatives
DE2909779A1 (de) * 1979-03-13 1980-09-18 Thomae Gmbh Dr K Neue indolderivate, deren herstellung und deren verwendung als arzneimittel

Also Published As

Publication number Publication date
ES517439A0 (es) 1984-12-01
AU9067582A (en) 1983-05-26
GB2111050A (en) 1983-06-29
CA1197249A (en) 1985-11-26
FI823938A0 (fi) 1982-11-17
AR243519A1 (es) 1993-08-31
DE3265892D1 (en) 1985-10-03
EP0080154B1 (de) 1985-08-28
ATE15196T1 (de) 1985-09-15
ES530126A0 (es) 1985-11-16
ES530127A0 (es) 1986-06-16
ES530128A0 (es) 1985-12-01
EP0080154A2 (de) 1983-06-01
AR241428A1 (es) 1992-07-31
NO823869L (no) 1983-05-20
KR840002368A (ko) 1984-06-25
ES8608508A1 (es) 1986-06-16
DK169104B1 (da) 1994-08-15
DK514182A (da) 1983-05-20
PH19212A (en) 1986-02-04
IL67284A (en) 1986-03-31
FI75344C (fi) 1988-06-09
AR243177A1 (es) 1993-07-30
ES8501755A1 (es) 1984-12-01
JPS5892677A (ja) 1983-06-02
ES8602750A1 (es) 1985-12-01
KR880002010B1 (ko) 1988-10-12
NO159929B (no) 1988-11-14
FI75344B (fi) 1988-02-29
FI823938L (fi) 1983-05-20
HU190425B (en) 1986-09-29
NO159929C (no) 1989-02-22
JPH029031B2 (fi) 1990-02-28
GB2111050B (en) 1985-09-11
EP0080154A3 (en) 1983-09-28
PT75870B (en) 1986-01-21
IE54156B1 (en) 1989-07-05
NZ202551A (en) 1985-11-08
AU564233B2 (en) 1987-08-06
ZA828505B (en) 1983-09-28
ES8601962A1 (es) 1985-11-16
PT75870A (en) 1982-12-01
GR77035B (fi) 1984-09-04

Similar Documents

Publication Publication Date Title
DE69725978T2 (de) Chalcon-derivate und medikamente die diese enthalten
JPS62114987A (ja) 新規４―ベンジル―１―（２ｈ）―フタラジノン―誘導体及びその製法
EP0022078B1 (de) Pyrazolochinoline, Verfahren zu ihrer Herstellung, und pharmazeutische Präparate enthaltend diese Verbindungen
US5128343A (en) Derivatives of pyrimidinyl-piperazinyl-alkyl azoles with anxiolytic and/or tranquilizing activity
EP0080154B1 (de) N-Substituierte 2-Pyridylindole, Verfahren zu ihrer Herstellung, pharmazeutische Präparate enthaltend diese Verbindungen, sowie ihre therapeutische Verwendung
EP0011142B1 (de) Pyrido (2,1-b) chinazolinon-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate
US4478842A (en) N-Substituted-2-pyridylindoles
DD224588A5 (de) Verfahren zur herstellung von n-pyridylindolen
EP0114573B1 (de) Imidazo(1,5-a)pyridin-Derivate
US4549022A (en) 4-Pyridone-3-carboxylic acid derivatives
EP0068386B1 (de) Substituierte Imidazo(1,5-a)pyridine, Verfahren zu ihrer Herstellung und pharmazeutische Präparate die diese Verbindungen enthalten
EP0107618B1 (en) N-substituted-2-(1-imidazolyl)-indoles
EP0129051B1 (de) Substituierte Indole
DE3306146A1 (de) Pyridin-derivate und ihre verwendung als arzneimittel
EP0114572A1 (de) Substituierte Imidazo(1,5-a)pyridine
US4551460A (en) Pyrido[2,1-b]quinazoline derivatives useful as agents for treatment of allergic conditions and vascular disorders involving thrombosis
US4639521A (en) Isoquinoline derivatives
US4460777A (en) N-Substituted-2-pyridylindoles
US4539410A (en) N-Substituted-2-(1-imidazolyl)indoles
US4294969A (en) Process for producing 2-bromo-3,5-disubstituted pyridines
US4279913A (en) Polysubstituted-2-(3-loweralkylamino-2-R1 O-propoxy)pyridines
JPH0625250A (ja) チエノ〔３，４−ｄ〕イミダゾール誘導体、その製造法およびそれを含有する循環器官用剤
DD202572A5 (de) Verfahren zur herstellung von neuen imidazo (1,5-a)-pyridinen
US4598149A (en) 3-amino-2-hydroxypropyl of pyrimidin-4-one useful as antihypertensive, cardioprotective, antiarrythmic, and antianginal agents
US4393212A (en) Certain nicotinic acid esters and corresponding nicotinonitriles

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee